INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,293 | +601.2% | 42,348 | +584.2% | 0.00% | – |
Q4 2022 | $327 | -99.9% | 6,189 | -45.9% | 0.00% | -100.0% |
Q3 2022 | $531,000 | +172.3% | 11,431 | +98.5% | 0.00% | – |
Q1 2021 | $195,000 | -77.1% | 5,758 | -78.5% | 0.00% | -100.0% |
Q4 2020 | $853,000 | +10.1% | 26,839 | -11.1% | 0.00% | 0.0% |
Q3 2020 | $775,000 | -37.9% | 30,207 | -37.9% | 0.00% | -50.0% |
Q2 2020 | $1,248,000 | +109.4% | 48,634 | +25.3% | 0.00% | +100.0% |
Q1 2020 | $596,000 | -53.7% | 38,825 | +3.4% | 0.00% | -66.7% |
Q4 2019 | $1,288,000 | +186.9% | 37,557 | -37.6% | 0.00% | +200.0% |
Q3 2019 | $449,000 | -36.8% | 60,211 | +84.0% | 0.00% | -50.0% |
Q3 2018 | $710,000 | +57.1% | 32,722 | +27.9% | 0.00% | 0.0% |
Q2 2018 | $452,000 | -32.5% | 25,587 | -19.6% | 0.00% | -93.1% |
Q1 2018 | $670,000 | +43.2% | 31,842 | -1.6% | 0.03% | +45.0% |
Q4 2017 | $468,000 | -19.4% | 32,367 | -12.2% | 0.02% | -16.7% |
Q3 2017 | $581,000 | +50.1% | 36,852 | +18.1% | 0.02% | +41.2% |
Q2 2017 | $387,000 | +19250.0% | 31,214 | +20168.8% | 0.02% | – |
Q1 2017 | $2,000 | -99.3% | 154 | -99.2% | 0.00% | -100.0% |
Q4 2016 | $278,000 | -82.4% | 18,475 | -82.1% | 0.02% | -84.1% |
Q3 2016 | $1,576,000 | +2990.2% | 103,463 | +5441.7% | 0.11% | +2575.0% |
Q1 2016 | $51,000 | -79.2% | 1,867 | -69.6% | 0.00% | -77.8% |
Q3 2015 | $245,000 | – | 6,143 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |